Clinical Research Facility Technician
+44 (0) 1392 726429
An investigation into the mechanisms of action of incretin based anti-diabetic therapies in the human vasculature.
Diabetes is classified as a disease of epidemic proportions by the world health organisation (WHO). A relatively new line of therapies based upon the incretin, GLP-1, has shown to possess potential therapeutic effects beyond its initial insulinotropic effects. Leighton's project is aiming to understand the mechanisms behind these anti-diabetic therapies upon the pathology behind vascular complications that are prevalent in diabetes.
MSc - Stem Cells and Regeneration
University of Bristol (2011 – 2013)
Research project: From Pluripotent stem cell to neuron; taking cues from the embryo
BSc – Applied Biological Sciences
University of the West of England (2006 – 2009)
Research Project: Genetic nuclear transformation of the ‘goldenrod’ fluorescent marker into the green algae, Chlamydomonas reinhardti via the pathogenic vector, Agrobacterium tumefaciens.